BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioNJ - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioNJ
X-ORIGINAL-URL:https://bionj.org
X-WR-CALDESC:Events for BioNJ
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240521T120000
DTEND;TZID=America/New_York:20240521T131500
DTSTAMP:20260503T131510
CREATED:20240419T194030Z
LAST-MODIFIED:20240520T183739Z
UID:11558-1716292800-1716297300@bionj.org
SUMMARY:Capital Markets Update / State of the Economy
DESCRIPTION:FREE Webinar: Capital Markets Update / State of the Economy \n\n\n\nTuesday\, May 21\, 2024 | 12:00 p.m.-1:15 p.m. \n\n\n\n\nRegister Today for FREE!\n\n\n\n\nJoin us for this insightful webinar where we’ll dive into crucial topics shaping the financial landscape. Our experts will discuss M&A collaborations and deals\, emerging technologies garnering funding and the impacts of the IRA. Plus\, you’ll gain valuable insights into the upcoming 2024 election’s potential ramifications on the economy. Don’t miss this opportunity to stay ahead in today’s dynamic market environment. Topics include: \n\n\n\n\nM & A Collaborations & Deals\n\n\n\nTechnologies that are being funded and those that are not\n\n\n\nIRA and its Impacts \n\n\n\nUpcoming 2024 Election\n\n\n\n\nSpeakers: \n\n\n\n\nKeith Gaub \n\n\n\nVice President & Assistant TreasurerBristol Myers Squibb \n\n\n\nMr. Gaub oversees Capital Markets\, Financial Risk Management\, International Treasury & International Treasury Operations\, Cash Leadership and Benefit Investments.  Prior to joining BMS\, he worked at Zoetis for nine years\, most recently serving as Senior Director of Investor Relations\, where he managed relationships with sell-side analysts and large institutional investors\, in addition to supporting their CEO and CFO during earnings announcements. \n\n\n\n\n\n\n\n\n\nCourtney Rickert McCaffrey \n\n\n\nGlobal Insights LeaderEY Geostrategic Business Group \n\n\n\nMs. McCaffrey drives market-leading insight around geopolitics\, corporate performance and political risk management. She leads the analysis of the annual EY Geostrategic Outlook and advises clients on how geopolitical developments may impact their companies’ operations and strategies\, and how to manage political risks more proactively. She is also the co-author of a forthcoming book entitled Geostrategy by Design: How to Manage Geopolitical Risk in the New Era of Globalization. \n\n\n\n\n\n\n\n\n\nPatrick Morley \n\n\n\nSenior Managing Director Equity Capital MarketsLeerink Partners \n\n\n\nMr. Morley is a Senior Managing Director in Leerink Partners’ Equity Capital Markets group\, advising private and public healthcare companies on the optimal strategy and tactics to achieve their financing goals. He joined the Firm in 2011 as a member of the Healthcare Investment Banking group before transitioning to his current role.  \n\n\n\n\n\n\n\n\n\nPhilip Sclafani \n\n\n\nPartnerPWC \n\n\n\nMr. Sclafani has deep experience supporting branded\, biotech\, generics\, medical device and other healthcare companies. He leads high performing teams to address his clients most challenging issues across strategy\, operations\, digital & analytics\, compliance and technology in the Pharma commercial organization\, medical affairs\, M&A / business development and other key functions. \n\n\n\n\n\n\n\n\n\nRoel van den Akker \n\n\n\nPharmaceutical and Life Sciences Deals LeaderPWC \n\n\n\nMr. van den Akker is PwC’s Pharmaceutical and Life Sciences Deals Leader\, with vast experience in transactions\, deals\, M&A and divestitures. He leads a team focused on helping pharma\, life sciences and med tech companies win through deals and seamlessly capture value during acquisitions. \n\n\n\n\n\n\n\n\n\nMODERATOR: Scott Megaffin \n\n\n\nPresident & CEOAdiso Therapeutics \n\n\n\nLeveraging his extensive experience as a biopharma senior executive\, Mr. Megaffin has guided both public and private companies as CEO and Board Director. His deep knowledge spans a broad range of therapeutic areas\, including immunology\, inflammation\, oncology\, anti-infectives\, pain\, critical care and virology. He currently applies his expertise beyond Adiso by serving on the board of BioNJ and Adastra. \n\n\n\n\n\n\n\n\n\n\n\nWhether you’re involved in M&A\, technology\, finance or in the broader economic landscape\, this webinar offers valuable insights tailored to pique your interests and expertise. Click here to register at no cost. \n\n\n\nWho should attend this webinar: This webinar is ideal for financial professionals\, investors\, business leaders\, policymakers and anyone interested in understanding the current state and future trends of the capital markets and the economy.
URL:https://bionj.org/event/capital-markets-update-state-of-the-economy/
LOCATION:New Jersey
CATEGORIES:BioNJ Event
ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/HECT-Best-Practices-1.png
END:VEVENT
END:VCALENDAR